RaQualia Pharma Inc
TSE:4579

Watchlist Manager
RaQualia Pharma Inc Logo
RaQualia Pharma Inc
TSE:4579
Watchlist
Price: 593 JPY -0.17% Market Closed
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

-718.6m
Operating Cash Flow
Growth Rates:
1 Year
-
3 Years
-148%
5 Years
-78%
7 Years
-6%
10 Years
+67%
-135.4m
+64%
Investing Cash Flow
Growth Rates:
1 Year
-184%
3 Years
-
5 Years
+63%
7 Years
+69%
10 Years
-
793.5m
-0.1%
Financing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
+700%
7 Years
-
10 Years
+157%

Cash Flow Statement
RaQualia Pharma Inc

Rotate your device to view
Cash Flow Statement
Currency: JPY
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Operating Cash Flow
Net Income
(1 102)
445
266
348
(632)
(2 031)
(2 018)
(2 151)
(1 848)
(1 346)
(1 169)
(905)
(723)
(880)
(774)
(644)
(60)
(295)
(354)
(422)
(1 078)
(874)
(797)
(772)
27
(140)
(66)
(63)
(528)
6
304
328
881
524
1 121
1 310
851
826
211
141
(294)
Depreciation & Amortization
68
61
56
54
21
26
30
40
53
66
77
80
80
80
81
83
86
88
98
111
126
138
142
141
140
131
125
125
124
132
138
142
142
141
144
146
148
147
150
160
176
Other Non-Cash Items
(1 036)
(2 569)
(2 304)
(2 347)
(1 590)
(125)
(114)
(110)
(59)
7
(13)
25
(79)
(101)
(158)
(188)
(94)
(27)
(4)
(18)
(54)
(122)
(75)
(52)
(32)
(38)
(47)
(17)
34
(50)
(59)
(79)
(138)
(60)
(99)
(133)
109
119
141
168
(33)
Cash Taxes Paid
6
11
9
9
9
19
21
25
6
(11)
(13)
(17)
2
2
2
2
2
15
17
19
32
28
28
28
24
81
80
98
93
74
73
77
77
118
148
185
184
143
105
108
110
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
2
3
5
6
7
7
6
7
Change in Working Capital
(109)
(106)
(118)
(150)
119
(80)
(132)
(60)
(263)
(540)
(433)
39
41
264
583
87
(239)
234
192
173
602
136
(45)
(26)
(666)
36
(187)
(126)
80
(458)
(268)
(24)
(518)
82
(558)
(566)
373
(196)
(347)
(346)
(567)
Cash from Operating Activities
(2 179)
N/A
(2 169)
+0%
(2 100)
+3%
(2 095)
+0%
(2 081)
+1%
(2 209)
-6%
(2 233)
-1%
(2 281)
-2%
(2 117)
+7%
(1 814)
+14%
(1 539)
+15%
(761)
+51%
(681)
+11%
(637)
+6%
(269)
+58%
(662)
-146%
(307)
+54%
1
N/A
(68)
N/A
(156)
-130%
(404)
-159%
(721)
-79%
(775)
-7%
(708)
+9%
(531)
+25%
(11)
+98%
(175)
-1 512%
(82)
+53%
(289)
-254%
(371)
-28%
115
N/A
368
+221%
366
0%
686
+87%
608
-11%
757
+25%
1 480
+95%
897
-39%
155
-83%
122
-21%
(719)
N/A
Investing Cash Flow
Capital Expenditures
(26)
(20)
(51)
(84)
(101)
(104)
(104)
(227)
(200)
(218)
(187)
(32)
(37)
(59)
(57)
(87)
(88)
(116)
(194)
(162)
(221)
(228)
(147)
(151)
(94)
(24)
(67)
(98)
(156)
(207)
(179)
(163)
(105)
0
(42)
(37)
(32)
(65)
(155)
(211)
(222)
Other Items
978
2 865
1 254
953
(695)
(2 078)
(84)
218
865
78
(161)
(470)
(404)
238
803
1 057
622
114
(649)
(448)
(147)
48
353
213
311
425
72
335
382
172
22
(345)
(174)
(322)
44
302
(16)
229
(96)
(162)
87
Cash from Investing Activities
952
N/A
2 845
+199%
1 202
-58%
869
-28%
(796)
N/A
(2 182)
-174%
(189)
+91%
(9)
+95%
666
N/A
(140)
N/A
(348)
-149%
(502)
-44%
(441)
+12%
180
N/A
746
+315%
970
+30%
534
-45%
(2)
N/A
(843)
-38 747%
(610)
+28%
(368)
+40%
(181)
+51%
206
N/A
62
-70%
216
+250%
401
+85%
5
-99%
237
+4 656%
225
-5%
(35)
N/A
(157)
-346%
(508)
-224%
(279)
+45%
(369)
-32%
1
N/A
265
+22 481%
(48)
N/A
164
N/A
(251)
N/A
(374)
-49%
(135)
+64%
Financing Cash Flow
Net Issuance of Common Stock
272
0
0
533
607
0
0
878
1 686
0
0
0
0
0
(0)
11
996
1 061
1 082
1 085
100
0
277
271
692
692
330
321
0
0
0
2
2
4
4
4
4
785
785
783
787
Net Issuance of Debt
0
0
110
140
140
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(0)
(13)
(15)
(18)
(32)
(16)
(25)
(34)
11
(5)
(8)
(12)
Other
38
0
0
15
15
0
0
15
15
0
0
0
0
0
0
0
11
0
0
0
(0)
5
4
4
4
0
0
0
0
(0)
0
0
0
0
0
0
0
19
19
19
19
Cash from Financing Activities
309
N/A
0
N/A
419
N/A
687
+64%
762
+11%
0
N/A
0
N/A
894
N/A
1 702
+90%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
11
+28 175%
1 007
+8 806%
1 072
+6%
1 093
+2%
1 096
+0%
99
-91%
39
-61%
380
+880%
374
-1%
696
+86%
691
-1%
330
-52%
320
-3%
(7)
N/A
0
N/A
(13)
N/A
(13)
-5%
(16)
-24%
(27)
-67%
(12)
+57%
(21)
-75%
(30)
-42%
815
N/A
798
-2%
794
-1%
793
0%
Change in Cash
Effect of Foreign Exchange Rates
63
25
29
72
85
116
121
63
1
(29)
(68)
(66)
(34)
(8)
24
40
(4)
(47)
(25)
(8)
28
83
27
11
(11)
(23)
(5)
(25)
(68)
17
35
54
109
73
115
145
36
3
18
18
46
Net Change in Cash
(855)
N/A
1 009
N/A
(450)
N/A
(467)
-4%
(2 031)
-335%
(3 513)
-73%
(1 649)
+53%
(1 334)
+19%
252
N/A
(281)
N/A
(253)
+10%
(446)
-76%
(1 156)
-159%
(465)
+60%
500
N/A
359
-28%
1 229
+243%
1 023
-17%
157
-85%
322
+105%
(644)
N/A
(781)
-21%
(162)
+79%
(261)
-61%
371
N/A
1 059
+186%
155
-85%
451
+191%
(139)
N/A
(389)
-180%
(20)
+95%
(100)
-411%
179
N/A
363
+102%
712
+96%
1 146
+61%
1 439
+26%
1 878
+31%
721
-62%
560
-22%
(15)
N/A
Free Cash Flow
Free Cash Flow
(2 205)
N/A
(2 190)
+1%
(2 151)
+2%
(2 179)
-1%
(2 182)
0%
(2 313)
-6%
(2 337)
-1%
(2 508)
-7%
(2 316)
+8%
(2 032)
+12%
(1 727)
+15%
(793)
+54%
(718)
+9%
(696)
+3%
(327)
+53%
(750)
-129%
(396)
+47%
(115)
+71%
(262)
-127%
(318)
-21%
(625)
-97%
(950)
-52%
(922)
+3%
(858)
+7%
(625)
+27%
(35)
+94%
(242)
-598%
(180)
+26%
(446)
-148%
(578)
-30%
(65)
+89%
204
N/A
261
+27%
686
+163%
565
-18%
720
+27%
1 448
+101%
831
-43%
(0)
N/A
(89)
-100 108%
(941)
-955%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.